MarketLens
Sign Up

Why is Boston Scientific Acquiring Penumbra

6 months ago
SHARE THIS ON:

Why is Boston Scientific Acquiring Penumbra

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News2 days ago

Boston Scientific Leans on Acquisitions to Drive Long-Term Growth

Boston Scientific is leaning on acquisitions to expand into high-growth markets, with the Penumbra deal adding a major thrombectomy opportunity. The strategy aims to drive long-term growth, though no ...
Stock News3 weeks ago

Why Boston Scientific Stock Crashed Today

Boston Scientific's stock fell after the company disclosed a global cybersecurity incident disrupting operations, with the investigation ongoing and the nature, scope, and impact still undetermined.
Stock News1 months ago

Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Boston Scientific CEO Michael Mahoney bought ~200,000 shares for ~$10.0 million on August 3, 2026, at $48.34, raising his total equity holdings by 13%. The insider purchase signals management confiden...

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

Generac, Amazon strike $2.4 billion long-term generator supply deal

Stock News2 hours ago

A Broad-Based Earnings Growth Picture as Revisions Stay Positive

Stock News2 hours ago

Why Intel Stock Jumped Today

Stock News2 hours ago

LARRY KUDLOW: Prosperity is as American as apple pie

Stock News2 hours ago

Diamondback Energy Inc (FANG) Stock Down 8.0% -- Now Undervalued? GF Score: 61/100